Catalyst Wire Dossier Catalyst Wire Dossier

Nevirapine (generic)

NEVIRAPINE · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nevirapine (generic), covering 2012-05-22 to 2024-03-21. Get the full timeline:

Most recent: FDA Approved: NEVIRAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing